Detalles de la búsqueda
1.
Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial.
J Card Fail;
2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802053
2.
Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
J Am Coll Cardiol;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744407
3.
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Eur J Heart Fail;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745498
4.
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination.
J Infect Dis;
2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717928
5.
Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to US Adults with Heart Failure.
J Card Fail;
2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740173
6.
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
Eur J Heart Fail;
2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742248
7.
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials.
Nat Med;
30(5): 1432-1439, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710952
8.
High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life.
JAMA Cardiol;
2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38809565
9.
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Eur J Heart Fail;
2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700986
10.
Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials.
Circulation;
2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733145
11.
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER.
JACC Heart Fail;
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573262
12.
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
Diabetes Obes Metab;
26(5): 1821-1829, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586966
13.
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial.
JAMA Cardiol;
2024 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583091
14.
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HF.
Eur J Heart Fail;
2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587090
15.
Sex Differences in Heart Failure With Improved Ejection Fraction: The DELIVER Trial.
JACC Heart Fail;
12(6): 1119-1122, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661586
16.
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation;
149(23): 1789-1801, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583093
17.
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
Int J Cardiol;
406: 132036, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599465
18.
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.
J Am Coll Cardiol;
83(22): 2148-2159, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588927
19.
Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
Eur Heart J;
45(20): 1856-1858, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596844
20.
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
Ann Intern Med;
177(4): 476-483, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498876